TA Scan

Equitable patient representation in clinical trials has been difficult to achieve. Each drug development plan requires thorough investigation as the incidence and prevalence in racial, ethnic, and socioeconomic subgroups varies strongly per disease area, and the inter-ethnic differences in drug response need careful analysis. ​ There is a lack of robust and reliable data on race, ethnicity, and socioeconomic characteristics on a global scale. Without adequate data to identify relevant population groups, inequities remain unseen and unaddressed. The available diversity data is challenging and exists in different forms and structures. ​ Despite these limitations, there is still a broad range of high-quality data that can be consolidated, standardized, and visualized to support streamlined diversity and site identification strategies across all indications. ​ TA Scan is a cloud-based clinical and commercial business intelligence tool that aggregates and connects global clinical trial data, presentation data, publication data, and many other data sources from the public domain into a single intuitive database. Our patented TrialCloud technology allows TA Scan to semantically link all data types, which supports the extraction of hidden insights. ​ In the past year, TA Scan fully integrated global demographic and diversity data to include population and patient data. TA Scan's data and built-in analytics allow users to easily streamline their global KOL, PI/site selection and diversity strategies, by assessing experience levels and intelligence around competitive drugs and clinical trials together with exposure to diverse populations. Data can be filtered and visualized within the TA Scan application and exported for analysis, or alternatively delivered via API."\